- Home
- STRO vs OCCI Comparison
STRO vs OCCI Comparison
Compare STRO & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- OCCI
- Stock Information
- Founded
- STRO 2003
- OCCI N/A
- Country
- STRO United States
- OCCI United States
- Employees
- STRO N/A
- OCCI N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- STRO Health Care
- OCCI Finance
- Exchange
- STRO Nasdaq
- OCCI Nasdaq
- Market Cap
- STRO 147.6M
- OCCI 146.7M
- IPO Year
- STRO 2018
- OCCI N/A
- Fundamental
- Price
- STRO $1.77
- OCCI $7.05
- Analyst Decision
- STRO Strong Buy
- OCCI
- Analyst Count
- STRO 7
- OCCI 0
- Target Price
- STRO $12.14
- OCCI N/A
- AVG Volume (30 Days)
- STRO 950.7K
- OCCI 115.8K
- Earning Date
- STRO 03-24-2025
- OCCI 12-11-2023
- Dividend Yield
- STRO N/A
- OCCI 24.32%
- EPS Growth
- STRO N/A
- OCCI N/A
- EPS
- STRO N/A
- OCCI N/A
- Revenue
- STRO $160,955,000.00
- OCCI N/A
- Revenue This Year
- STRO N/A
- OCCI N/A
- Revenue Next Year
- STRO N/A
- OCCI $10.19
- P/E Ratio
- STRO N/A
- OCCI N/A
- Revenue Growth
- STRO 230.90
- OCCI N/A
- 52 Week Low
- STRO $1.51
- OCCI $5.47
- 52 Week High
- STRO $6.13
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- STRO 42.89
- OCCI 43.26
- Support Level
- STRO $1.76
- OCCI $7.05
- Resistance Level
- STRO $1.95
- OCCI $7.32
- Average True Range (ATR)
- STRO 0.13
- OCCI 0.06
- MACD
- STRO 0.00
- OCCI -0.00
- Stochastic Oscillator
- STRO 41.94
- OCCI 5.17
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.